Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Decay Kinetics of HIV With the Integrase Inhibitor Raltegravir

NCT00863668 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT00863668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00863668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Decay Kinetics of HIV With the Integrase Inhibitor Raltegravir
Lead sponsor
University of Minnesota
Phase
Not applicable
Overall status
Withdrawn
Start date
March 31, 2009
Completion date
March 31, 2011
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, hiv infections